person · Reporting owner

Black Jeffrey G.

Disclosed activity across 4 companies

Tapewire entity: 936
SEC CIK: 0001449439

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Alphatec Holdings, Inc.ATEC · Entity 4720	EVP & CFO	March 09, 2021	March 10, 2021
EXAGEN INC.XGN · Entity 935	Chief Financial Officer	September 01, 2026	September 02, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Alphatec Holdings, Inc.

Report date March 09, 2021 · Filed March 10, 2021

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	620,770	Reported balance After 2021-03-09 transaction · row 1 1 source row Row 1 · 2021-03-09 · Sale · Disposed 7,000 · Balance 620,770 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2019, as amended November 27, 2020, to satisfy certain tax withholding obligations of the reporting person resulting from the vesting of previously granted restricted stock unit awards. F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.12 to $17.10, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Common StockSEC Table I · non-derivative	IndirectBy IRA	49,874	Reported balance Holding disclosure · report date 2021-03-09 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 49,874

Filing footnotes · ownership attribution and instrument terms

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2019, as amended November 27, 2020, to satisfy certain tax withholding obligations of the reporting person resulting from the vesting of previously granted restricted stock unit awards.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.12 to $17.10, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

EXAGEN INC.

Report date September 01, 2026 · Filed September 02, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	323,339	Reported balance After 2026-09-01 transaction · row 1 Account or security details depend on footnotes; rows are not merged. 1 source row Row 1 · 2026-09-01 · Sale · Disposed 20,614 · Balance 323,339 F1: The sale reported on this Form 4 represents shares sold by the Reporting Person, at the direction of the Issuer, to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated solely by the Issuer and does not represent a discretionary transaction by the Reporting Person.
Common StockSEC Table I · non-derivative	Direct	324,910	Reported balance After 2026-09-01 transaction · row 2 Account or security details depend on footnotes; rows are not merged. 1 source row Row 2 · 2026-09-01 · Grant · Acquired 1,571 · Balance 324,910 F2: The reporting person is voluntarily reporting the acquisition of the common stock pursuant to the Issuer's Employee Stock Purchase Plan ("ESPP"). F3: Represents shares of common stock purchased through the ESPP in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Filing footnotes · ownership attribution and instrument terms

F1: The sale reported on this Form 4 represents shares sold by the Reporting Person, at the direction of the Issuer, to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated solely by the Issuer and does not represent a discretionary transaction by the Reporting Person.

F2: The reporting person is voluntarily reporting the acquisition of the common stock pursuant to the Issuer's Employee Stock Purchase Plan ("ESPP").

F3: Represents shares of common stock purchased through the ESPP in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Past disclosures · reporting ended (2)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Apollo Endosurgery, Inc.

Report date April 04, 2023 · Filed April 04, 2023

Section 16 reporting ended · disclosed 2023-04-04. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Common StockSEC Table I · non-derivative	Direct	Reported balance After 2023-04-04 transaction · row 1 1 source row Row 1 · 2023-04-04 · Disposition to issuer · Disposed 335,330 · Balance 0 F1: Reflects the disposition of the reporting person's 103,750 shares of Issuer common stock, par value $0.001 per share ("Issuer Common Stock"), upon the consummation of the transactions contemplated by the Agreement and Plan of Merger (the "Merger Agreement"), dated as of November 29, 2022, among the Issuer, Boston Scientific Corporation ("Parent") and Textile Merger Sub, Inc., an indirect wholly owned subsidiary of Parent ("Merger Sub"), including the consummation of the merger between Issuer and Merger Sub on April 4, 2023 (the "Merger"). Pursuant to the Merger Agreement, at the effective time of the Merger (the "Effective Time"), each outstanding share of Issuer Common Stock, was canceled and converted automatically into the right to receive $10.00 in cash, without interest (the "Merger Consideration"), less applicable taxes and authorized deductions. F2: Reflects the disposition of the reporting person's 82,680 shares of Issuer PSUs upon the consummation of the Merger. Pursuant to the Merger Agreement, at the Effective Time, each outstanding performance restricted stock unit award granted under any Issuer Stock Plan that vests based on achievement of any performance condition and the passage of time (each, an "Issuer PSU"), whether vested but unsettled or unvested, was canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (1) the Merger Consideration and (2) the aggregate number of shares of Issuer Common Stock underlying such Issuer PSU (determined as if all performance conditions in the applicable award agreements relating to such Issuer PSU have been satisfied as of immediately prior to the Effective Time), less applicable taxes and authorized deductions. F3: Includes 2,680 Issuer PSUs which were previously withheld in error by the Issuer in connection with the net settlement of the reporting person's Issuer PSUs. F4: Reflects the disposition of the reporting person's 148,900 shares of Issuer RSUs upon the consummation of the Merger. Pursuant to the Merger Agreement, at the Effective Time, each outstanding restricted stock unit award granted under any Issuer Stock Plan (each, an "Issuer RSU"), whether vested but unsettled or unvested, was canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (1) the Merger Consideration and (2) the aggregate number of shares of Issuer Common Stock underlying such Issuer RSU, less applicable taxes and authorized deductions.
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.69 · Expires 2031-08-09	Direct	Reported balance After 2023-04-04 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2023-04-04 · Disposition to issuer · Disposed 150,000 · Balance 0 F5: Pursuant to the Merger Agreement, at the Effective Time, each outstanding and unexercised option to purchase shares of Issuer Common Stock granted under the Issuer's 2006 Stock Option Plan, 2016 Equity Incentive Plan or 2017 Equity Incentive Plan or pursuant to the "inducement" grant exception under Rule 5635(c)(4) of the Nasdaq Listing Rules (collectively, the "Issuer Stock Plans", and each such option, an "Issuer Option"), whether vested or unvested, was canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (1) the amount by which the Merger Consideration exceeds the exercise price per share applicable to such Issuer Option and (2) the aggregate number of shares of Issuer Common Stock issuable upon exercise of such Issuer Option, less applicable taxes and authorized deductions.
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.95 · Expires 2032-06-14	Direct	Reported balance After 2023-04-04 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2023-04-04 · Disposition to issuer · Disposed 120,834 · Balance 0 F5: Pursuant to the Merger Agreement, at the Effective Time, each outstanding and unexercised option to purchase shares of Issuer Common Stock granted under the Issuer's 2006 Stock Option Plan, 2016 Equity Incentive Plan or 2017 Equity Incentive Plan or pursuant to the "inducement" grant exception under Rule 5635(c)(4) of the Nasdaq Listing Rules (collectively, the "Issuer Stock Plans", and each such option, an "Issuer Option"), whether vested or unvested, was canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (1) the amount by which the Merger Consideration exceeds the exercise price per share applicable to such Issuer Option and (2) the aggregate number of shares of Issuer Common Stock issuable upon exercise of such Issuer Option, less applicable taxes and authorized deductions.

Filing footnotes · ownership attribution and instrument terms

F1: Reflects the disposition of the reporting person's 103,750 shares of Issuer common stock, par value $0.001 per share ("Issuer Common Stock"), upon the consummation of the transactions contemplated by the Agreement and Plan of Merger (the "Merger Agreement"), dated as of November 29, 2022, among the Issuer, Boston Scientific Corporation ("Parent") and Textile Merger Sub, Inc., an indirect wholly owned subsidiary of Parent ("Merger Sub"), including the consummation of the merger between Issuer and Merger Sub on April 4, 2023 (the "Merger"). Pursuant to the Merger Agreement, at the effective time of the Merger (the "Effective Time"), each outstanding share of Issuer Common Stock, was canceled and converted automatically into the right to receive $10.00 in cash, without interest (the "Merger Consideration"), less applicable taxes and authorized deductions.

F2: Reflects the disposition of the reporting person's 82,680 shares of Issuer PSUs upon the consummation of the Merger. Pursuant to the Merger Agreement, at the Effective Time, each outstanding performance restricted stock unit award granted under any Issuer Stock Plan that vests based on achievement of any performance condition and the passage of time (each, an "Issuer PSU"), whether vested but unsettled or unvested, was canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (1) the Merger Consideration and (2) the aggregate number of shares of Issuer Common Stock underlying such Issuer PSU (determined as if all performance conditions in the applicable award agreements relating to such Issuer PSU have been satisfied as of immediately prior to the Effective Time), less applicable taxes and authorized deductions.

F3: Includes 2,680 Issuer PSUs which were previously withheld in error by the Issuer in connection with the net settlement of the reporting person's Issuer PSUs.

F4: Reflects the disposition of the reporting person's 148,900 shares of Issuer RSUs upon the consummation of the Merger. Pursuant to the Merger Agreement, at the Effective Time, each outstanding restricted stock unit award granted under any Issuer Stock Plan (each, an "Issuer RSU"), whether vested but unsettled or unvested, was canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (1) the Merger Consideration and (2) the aggregate number of shares of Issuer Common Stock underlying such Issuer RSU, less applicable taxes and authorized deductions.

F5: Pursuant to the Merger Agreement, at the Effective Time, each outstanding and unexercised option to purchase shares of Issuer Common Stock granted under the Issuer's 2006 Stock Option Plan, 2016 Equity Incentive Plan or 2017 Equity Incentive Plan or pursuant to the "inducement" grant exception under Rule 5635(c)(4) of the Nasdaq Listing Rules (collectively, the "Issuer Stock Plans", and each such option, an "Issuer Option"), whether vested or unvested, was canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (1) the amount by which the Merger Consideration exceeds the exercise price per share applicable to such Issuer Option and (2) the aggregate number of shares of Issuer Common Stock issuable upon exercise of such Issuer Option, less applicable taxes and authorized deductions.

STANDARD BIOTOOLS INC.

Report date August 20, 2024 · Filed September 05, 2024

Section 16 reporting ended · disclosed 2024-09-05. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	421,608	Reported balance After 2024-08-20 transaction · row 1 1 source row Row 1 · 2024-08-20 · Tax withholding · Disposed 6,690 · Balance 421,608 F1: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units granted to the reporting person on May 20, 2024, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on May 21, 2024.

Filing footnotes · ownership attribution and instrument terms

F1: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units granted to the reporting person on May 20, 2024, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on May 21, 2024.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
July 30, 2018 Filed Aug 1, 2018 20:31 UTC	Alphatec Holdings, Inc. ATEC · Entity 4720	GrantCommon Stock	102,041	$0.00	$0.00	Disclosure SEC source: 0001179110-18-010079 · edgar.xml · nonDerivative · entry 1 Black Jeffrey G. · CIK 0001449439 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,041 F1 · date: On July 30, 2018, issuer granted to the reporting person 102,041 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. F2 · date: The restricted stock units vest in four equal installments on each of the first four anniversaries of the grant date. F1 · shares: On July 30, 2018, issuer granted to the reporting person 102,041 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. F2 · shares: The restricted stock units vest in four equal installments on each of the first four anniversaries of the grant date. F1 · balance_after: On July 30, 2018, issuer granted to the reporting person 102,041 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. F2 · balance_after: The restricted stock units vest in four equal installments on each of the first four anniversaries of the grant date. Read SEC document
May 17, 2018 Filed May 21, 2018 18:59 UTC	Alphatec Holdings, Inc. ATEC · Entity 4720	Exercise / conversionSeries B Convertible Preferred Stock · Derivative	50	$0.00	$0.00	Disclosure SEC source: 0001179110-18-007275 · edgar.xml · derivative · entry 3 Black Jeffrey G. · CIK 0001449439 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Indirect · By IRA Disclosed balance after: 0 Underlying: Common Stock · 15,874 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series B Convertible Preferred Stock had no expiration date and converted into 317.4603 shares of the issuer's common stock on May 17, 2018, the date that issuer's stockholders approved such conversion. F1 · derivative.exercise_date: Each share of Series B Convertible Preferred Stock had no expiration date and converted into 317.4603 shares of the issuer's common stock on May 17, 2018, the date that issuer's stockholders approved such conversion. F1 · derivative.expiration_date: Each share of Series B Convertible Preferred Stock had no expiration date and converted into 317.4603 shares of the issuer's common stock on May 17, 2018, the date that issuer's stockholders approved such conversion. F2 · derivative.underlying_shares: Due to a rounding error, Reporting Person's Form 4 filing dated March 12, 2018 incorrectly stated that the number of shares of common stock underlying the Series B Convertible Preferred Stock purchased by Reporting Person on March 8, 2018 was 15,873. The actual number of underlying shares was 15,874, which is reflected in this Form 4. Read SEC document
May 17, 2018 Filed May 21, 2018 18:59 UTC	Alphatec Holdings, Inc. ATEC · Entity 4720	Exercise / conversionCommon Stock	15,874	$0.00	$0.00	Disclosure SEC source: 0001179110-18-007275 · edgar.xml · nonDerivative · entry 1 Black Jeffrey G. · CIK 0001449439 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Indirect · By IRA Disclosed balance after: 49,874 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Due to a rounding error, Reporting Person's Form 4 filing dated March 12, 2018 incorrectly stated that the number of shares of common stock underlying the Series B Convertible Preferred Stock purchased by Reporting Person on March 8, 2018 was 15,873. The actual number of underlying shares was 15,874, which is reflected in this Form 4. F1 · price: Each share of Series B Convertible Preferred Stock had no expiration date and converted into 317.4603 shares of the issuer's common stock on May 17, 2018, the date that issuer's stockholders approved such conversion. Read SEC document
March 08, 2018 Filed Mar 12, 2018 18:11 UTC	Alphatec Holdings, Inc. ATEC · Entity 4720	GrantWarrants (right to buy) · Derivative	13,492	$0.00 Strike: $3.50	$0.00	Disclosure SEC source: 0001179110-18-004080 · edgar.xml · derivative · entry 2 Black Jeffrey G. · CIK 0001449439 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Indirect · By IRA Disclosed balance after: 13,492 Underlying: Common Stock · 13,492 shares Expires not disclosed F2 · derivative.exercise_date: Each Warrant is exercisable for 1 share of the issuer's common stock for a period of five years following the date that stockholder approval is obtained. F2 · derivative.expiration_date: Each Warrant is exercisable for 1 share of the issuer's common stock for a period of five years following the date that stockholder approval is obtained. Read SEC document
March 08, 2018 Filed Mar 12, 2018 18:11 UTC	Alphatec Holdings, Inc. ATEC · Entity 4720	GrantSeries B Convertible Preferred Stock · Derivative	50	$1,000.00	$50,000.00	Disclosure SEC source: 0001179110-18-004080 · edgar.xml · derivative · entry 1 Black Jeffrey G. · CIK 0001449439 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Indirect · By IRA Disclosed balance after: 50 Underlying: Common Stock · 15,873 shares Expires not disclosed F1 · derivative.exercise_price: Each share of Series B Convertible Preferred Stock has no expiration date and is convertible into 317.4603 shares of the issuer's common stock following the date that stockholder approval is obtained. F1 · derivative.exercise_date: Each share of Series B Convertible Preferred Stock has no expiration date and is convertible into 317.4603 shares of the issuer's common stock following the date that stockholder approval is obtained. F1 · derivative.expiration_date: Each share of Series B Convertible Preferred Stock has no expiration date and is convertible into 317.4603 shares of the issuer's common stock following the date that stockholder approval is obtained. Read SEC document
August 17, 2017 Filed Aug 17, 2017 16:36 UTC	Alphatec Holdings, Inc. ATEC · Entity 4720	PurchaseCommon Stock	5,000	$1.80	$9,000.00	Disclosure SEC source: 0001179110-17-011620 · edgar.xml · nonDerivative · entry 1 Black Jeffrey G. · CIK 0001449439 · Executive VP & CFO 10b5-1 filing: Not disclosed Ownership: Indirect · by IRA Disclosed balance after: 34,000 F1 · balance_after: Reporting Person's Form 4 filing dated August 16, 2017, for purchase of 4,000 shares of common stock, incorrectly specified the Ownership Form of those shares as "Direct." The correct Ownership Form of those shares should have been labeled "Indirect," with the Nature of the Beneficial Ownership being identified as "by IRA." For purposes of Item 5 of this Form 4, those 4,000 shares of common stock purchased on August 16 have been moved from "Direct" to "Indirect" as the correct Ownership Form. Read SEC document
August 16, 2017 Filed Aug 16, 2017 17:40 UTC	Alphatec Holdings, Inc. ATEC · Entity 4720	PurchaseCommon Stock	4,000	$1.75	$7,000.00	Disclosure SEC source: 0001179110-17-011547 · edgar.xml · nonDerivative · entry 1 Black Jeffrey G. · CIK 0001449439 · Executive VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,000 Read SEC document
July 26, 2017 Filed Jul 27, 2017 19:16 UTC	Alphatec Holdings, Inc. ATEC · Entity 4720	GrantEmployee Stock Option (right to buy) · Derivative	193,000	$0.00 Strike: $1.68	$0.00	Disclosure SEC source: 0001179110-17-010752 · edgar.xml · derivative · entry 1 Black Jeffrey G. · CIK 0001449439 · Executive VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 193,000 Underlying: Common Stock · 193,000 shares Expires 2027-07-26 F1 · derivative.exercise_date: The option vests over four years with 25% vesting on the first anniversary of the grant date and the remaining 75% vesting in 36 installments every month for the three years thereafter; provided, however, that no portion of the option shall be exercisable at any time unless and until the publicly-traded stock price for the securities underlying the option reaches a 30-day average trading price equal to or above $3.00 per share. Should the publicly-traded stock price for the securities underlying the option reach a 30-day average trading price at or above $3.00 per share, this pricing condition on the exercise of the option shall be satisfied, and shall terminate. Read SEC document
July 14, 2017 Filed Jul 14, 2017 12:43 UTC	Alphatec Holdings, Inc. ATEC · Entity 4720	Exercise / conversionSeries A Convertible Preferred Stock · Derivative	50	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001179110-17-010369 · edgar.xml · derivative · entry 3 Black Jeffrey G. · CIK 0001449439 · Executive VP & CFO 10b5-1 filing: Not disclosed Ownership: Indirect · by IRA Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each share of Series A Convertible Preferred Stock has no expiration date and is convertible into 500 shares of the Issuer's common stock following the date that shareholders approve such conversion, which approval was obtained on June 15, 2017. F1 · derivative.expiration_date: Each share of Series A Convertible Preferred Stock has no expiration date and is convertible into 500 shares of the Issuer's common stock following the date that shareholders approve such conversion, which approval was obtained on June 15, 2017. Read SEC document
July 14, 2017 Filed Jul 14, 2017 12:43 UTC	Alphatec Holdings, Inc. ATEC · Entity 4720	Exercise / conversionCommon Stock	25,000	$0.00	$0.00	Disclosure SEC source: 0001179110-17-010369 · edgar.xml · nonDerivative · entry 2 Black Jeffrey G. · CIK 0001449439 · Executive VP & CFO 10b5-1 filing: Not disclosed Ownership: Indirect · by IRA Disclosed balance after: 25,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
March 31, 2017 Filed Mar 31, 2017 16:39 UTC	Alphatec Holdings, Inc. ATEC · Entity 4720	GrantCommon Stock - Restricted Stock Units	75,000	$0.00	$0.00	Disclosure SEC source: 0000899243-17-009011 · doc4.xml · nonDerivative · entry 1 Black Jeffrey G. · CIK 0001449439 · Executive VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 F1 · security: The restricted stock units ("RSUs") vest annually within 25% vesting on the anniversary of the grant date, and 25% vesting each anniversary thereafter. F2 · shares: Each RSU represents a contingent right to receive one share of the issuer's common stock. Read SEC document
March 29, 2017 Filed Mar 31, 2017 16:39 UTC	Alphatec Holdings, Inc. ATEC · Entity 4720	GrantWarrants (right to buy) · Derivative	25,000	$0.00 Strike: $2.00	$0.00	Disclosure SEC source: 0000899243-17-009011 · doc4.xml · derivative · entry 3 Black Jeffrey G. · CIK 0001449439 · Executive VP & CFO 10b5-1 filing: Not disclosed Ownership: Indirect · by IRA Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires not disclosed F4 · derivative.exercise_date: Each Warrant is exercisable for 1 share of the issuer's common stock for a period of five years following that date that shareholder approval is obtained. F4 · derivative.expiration_date: Each Warrant is exercisable for 1 share of the issuer's common stock for a period of five years following that date that shareholder approval is obtained. Read SEC document
March 29, 2017 Filed Mar 31, 2017 16:39 UTC	Alphatec Holdings, Inc. ATEC · Entity 4720	GrantSeries A Convertible Preferred Stock · Derivative	50	$1,000.00 Strike: $2.00	$50,000.00	Disclosure SEC source: 0000899243-17-009011 · doc4.xml · derivative · entry 2 Black Jeffrey G. · CIK 0001449439 · Executive VP & CFO 10b5-1 filing: Not disclosed Ownership: Indirect · by IRA Disclosed balance after: 50 Underlying: Common Stock · 25,000 shares Expires not disclosed F3 · derivative.exercise_date: Each share of Series A Convertible Preferred Stock has no expiration date and is convertible into 500 shares of the issuer's common stock following that date that shareholder approval is obtained. F3 · derivative.expiration_date: Each share of Series A Convertible Preferred Stock has no expiration date and is convertible into 500 shares of the issuer's common stock following that date that shareholder approval is obtained. Read SEC document
March 06, 2017 Filed Mar 15, 2017 20:20 UTC	Alphatec Holdings, Inc. ATEC · Entity 4720	GrantStock Option (Right to Buy) · Derivative	75,000	$0.00 Strike: $4.10	$0.00	Disclosure SEC source: 0000899243-17-007671 · doc4.xml · derivative · entry 1 Black Jeffrey G. · CIK 0001449439 · Executive VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2027-03-05 F1 · derivative.exercise_date: The options vest over four years with 25% vesting on the anniversary of the grant date and the remaining 75% vesting in 36 installments every month for the three years thereafter. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.